Sedation During Pediatric Diagnostic Gastrointestinal Endoscopy Gastrointestinal Endoscopy

Assiut University60 enrolled

Overview

comparison between propofol-fentanyl and propofol-ketamine for sedation in pediatric diagnostic gastrointestinal endoscopy.

It is a prospective double blinded controlled study that will be carried out on 60 pediatric patients undergoing GIT endoscopy; they will be divided into two groups of 30 patients each:- Group I (PF): will receive 0.5 µg/ kg fentanyl + 2 mg/ kg propofol IV. Group II (KF): will receive Ketofol (1 ketamine: 4 propofol) 0.5 mg/kg ketamine + 2 mg/kg propofol IV.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Sedation

Interventions

FentanylDRUG

fentanyl used with propofol for sedation

KetamineDRUG

ketamine used with propofol for sedation

Eligibility

Sex: ALLMin age: 6 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Pediatric patients undergoing diagnostic GIT endoscopy * ASA I-II Exclusion Criteria: * Emergency endoscopy * Respiratory infection and hyperactive airways * History of serious adverse effects related to anesthetics (e.g. allergic reactions), a family history of reactions to the study drugs * Morbid obesity, and neuropsychiatric disorders

Outcomes

Primary Outcomes

incidence of desaturation

when oxygen saturation below 90%

Time frame: up to 2 days after operation

Central Contacts

Mohamed Aly

CONTACT

00201062011126 galalm1967@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.